Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jan 15;2(1):145-149.
doi: 10.1016/j.jaccas.2019.11.050. eCollection 2020 Jan.

Transcatheter Mitral Valve-In-Valve Implantation: An Option for Failed Bioprosthetic Mitral Valve Stenosis During Pregnancy

Sophie Ribeyrolles  1 , Christelle Diakov  1 , Aurélie Veugeois  1 , Alain Berrebi  1 , Christophe Caussin  1
Affiliations
Case Reports

Transcatheter Mitral Valve-In-Valve Implantation: An Option for Failed Bioprosthetic Mitral Valve Stenosis During Pregnancy

Sophie Ribeyrolles et al. JACC Case Rep. .

Abstract

A pregnant woman presented with symptomatic bioprosthetic mitral valve stenosis. We discuss the difficulties of decision making in this particular situation where two lives are at stake, the fetus's and the mother's, questioning whether transcatheter mitral valve-in-valve implantation can be an effective and safe option for this challenging condition. (Level of Difficulty: Advanced.).

Keywords: BPMV, bioprosthetic mitral valve; MVS, mitral valve stenosis; TMVI, transcatheter mitral valve implantation; TTE, transthoracic echocardiography; VKA, vitamin K antagonists; echocardiography; mitral valve; pregnancy; valve replacement.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Bioprosthetic Mitral Valve Stenosis–Transthoracic Echocardiography (A) Parasternal long-axis view showing a calcified thickened mitral bioprosthesis. (B) Continuous-wave Doppler showing a transmitral mean gradient of 26 mm Hg, indicating severe bioprosthesis stenosis.
Figure 2
Figure 2
Bioprosthetic Mitral Valve Stenosis–Transesophageal Echocardiography The 3D en face view, showing a limited opening of the mitral bioprosthesis in systole and thickened leaflets.
Figure 3
Figure 3
Transcatheter Mitral Valve-In-Valve Implantation Transesophageal echocardiography. (A) Positioning the catheter through the bioprosthetic mitral valve. (B) Implantation of the new bioprosthetic mitral valve: inflating the balloon.
Figure 4
Figure 4
Transcatheter Mitral Valve-In-Valve Implantation: Before and After the Procedure Transesophageal echocardiography. (A) Before transcatheter mitral valve-in-valve implantation, the mean transmitral gradient was 26 mm Hg. (B) After the procedure, the mean transmitral gradient was 6 mm Hg.
See this image and copyright information in PMC

References

    1. Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–3241. - PubMed
    1. Patel A., Asopa S., Tang A., Otri S.K. Cardiac surgery during pregnancy. Tex Heart Inst J. 2008;35:307–312. - PMC - PubMed
    1. Chengode S., Shabadi R.V., Rao R.N., Alkemyani N., Alsabti H. Perioperative management of transcatheter, aortic and mitral, double valve-in-valve implantation during pregnancy through left ventricular apical approach. Ann Card Anaesth. 2018;21:185–188. - PMC - PubMed
    1. Urena M., Brochet E., Lecomte M. Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience. Eur Heart J. 2018;39:2679–2689. - PubMed
    1. Yoon S.H., Whisenant B.K., Bleiziffer S. Outcomes of transcatheter mitral valve replacement for degenerated bioprosthesis, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–451. - PubMed

Publication types

LinkOut - more resources